OPENLANE’s chief legal officer sells $1.41 million of stock after exercising options (NYSE: OPLN)

What happened

Charles S. Coleman, the executive vice president, chief legal officer and secretary of OPENLANE, Inc. (NYSE: OPLN), sold 39,976 shares for about $1.41 million. He kept 74,334 shares, and the Form 4 says the sold shares came from stock options exercised the same day.

Coleman sold 1,207 shares on Nov. 9 at a weighted average price of $35.01 and 38,769 shares on Nov. 10 at a weighted average of $35.21. He signed the Form 4 on Nov. 12.

Four option exercises fed the sales. Options with an $18.23 exercise price, granted June 4, 2021, and options at $13.81, granted March 4, 2021, were both exercised. Each grant expires in 2031, and the form lists zero options left in either.

Key numbers

Metric	Latest	Change	Source
Shares sold (Nov. 9 to Nov. 10)	39,976 shares		SEC Form 4
Total value of shares sold	$1.41 million		SEC Form 4
Shares held after the sales	74,334 shares		SEC Form 4
Weighted average sale price, Nov. 10	$35.21		SEC Form 4
Shares sold as a share of the 114,310-share holding with exercised shares	35.0%		Calculated from SEC Form 4

Read more: OPENLANE (OPLN) company research

Why it matters

The trade was a partial reduction, not an exit. OptimistFi calculates that the shares sold were 35.0% of the 114,310 shares Coleman held once the exercised shares were counted.

Every exercise was matched by a sale of the same size. The sales therefore turned options into cash and left the share count Coleman held before the exercises unchanged.

Both weighted average sale prices, from Nov. 9 and Nov. 10, were above the exercise price of each grant. The options were therefore in the money when Coleman exercised and sold, and the form reports the sales and exercises on the same days.

OptimistFi has argued that OPENLANE's marketplace, floorplan financing and ancillary services make the platform defensible if the technology transformation succeeds. The sale leaves that case unchanged, because it involves option shares rather than operating results.

The same facts limit the signal. The sale was tied to option exercises and Coleman still holds a sizable position, so it is a weak read on his view of the company.

Stock perps: every US stock that trades as a perpetual future, by leverage, live

What's next

The next scheduled test is OPENLANE's next quarterly report. Evidence there that the marketplace is lifting take-rates and that the technology transformation is on track would support OptimistFi's case, and weaker results would challenge it.

More from OptimistFi

• OPLN stock: research and coverage of OPENLANE
• Stock research on every company OptimistFi covers

From OptimistFi Perps